Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:7/7/2009

VIENNA, Va., July 7 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE Amex: CVM) to its shareholders:

Dear Fellow Shareholders:

Recently we have been hearing a great deal about the pandemic caused by the H1N1 swine flu. You may think to yourself, this is no big deal since it does not seem that serious and, look what happened to bird flu - it disappeared. Wrong - on both counts! In this letter I will show you where in the world, outside of the Far East, we already have a potent reservoir of bird flu just waiting to "meet" the swine flu. Once one person infected with a combined bird/swine flu virus gets on a plane, there will be no way to contain that next stage of the continuing pandemic. CEL-SCI scientists and their collaborators are in the process of trying to develop a vaccine/treatment for this eventuality.

Before I get into more details, I want to thank my fellow shareholders for supporting us during the past 9 months of the financial crisis. The crisis severely tested us and we have become better at what we do. In the process we have also defined CEL-SCI to work in three separate business units, all designed to support each other to make an enormous difference for the world and create financial success for our shareholders.

The three business units are:

1) Vaccines/treatment: H1N1 (swine) and other influenza viruses, as

well as a vaccine for rheumatoid arthritis.

2) Unique contract manufacturing services using our new manufacturing

facility near Baltimore, MD to generate additional revenue streams.

3) Our late-stage non-toxic cancer immunotherapy, Multikine, designed

to make the first cancer treatment more successful.

'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
3. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. CEL-SCI Takes Delivery of New Manufacturing Facility
6. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Announces 2008 Financial Results
9. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
10. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
11. CEL-SCIs L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... LONDON , May 29, 2015 ... forward as p ersonalized   treatments enter ... Despite generic erosion facing several of ... xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global ... growth by the end of the decade.   ...
(Date:5/29/2015)... 29, 2015 Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces that results of a large, European ... patients with hepatic metastases with the Delcath Hepatic ... an on-line abstract at the American Society of ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences® today ... in which researchers utilized Caris Molecular Intelligence®, the ... potential therapeutic targets in patients with colorectal and ... programmed cell death protein 1 (PD-1) and its ... at the 2015 American Society of Clinical Oncology ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... their offering. This report deals with ... classical use mainly to describe the chromosome structure ... age of molecular biology, it is also referred ...
Breaking Biology Technology:Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 2Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3
... China, Aug. 4 /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, Inc. ... Company"), a leading manufacturer and distributor,of high-quality, ... that it has retained Grayling Global to ... to shareholders, the investment,community and financial media., ...
... CryoLife, Inc. (NYSE: CRY ), a,biomaterials, medical device ... has been promoted to vice president of U.S. sales,and ... to vice,president of international sales and marketing. Both men ... worldwide sales and marketing.,Additionally, the company has announced the ...
... Radiometer today announced it,has received 510(k) clearance from ... FLEX CO-OX, a portable blood gas analyzer that ... expects commercial release,of the instrument to soon follow., ... The ABL80 FLEX CO-OX accurately measures pH, blood ...
Cached Biology Technology:Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel 2Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel 3CryoLife Announces Management Promotions 2CryoLife Announces Management Promotions 3New CO-oximetry Module for the ABL80 FLEX Blood Gas Analyzer 2
(Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... GAINESVILLE, Fla. New University of Florida research puts to ... the last glacial period. It turns out it ended up ... The findings have implications for modern-day global warming, said ... of the paper, which is published in this week,s journal ...
... team of researchers based at the Institute of Vertebrate ... professor at Washington University in St. Louis, has discovered ... anthropologists perceptions of the emergence of modern humans in ... published Oct. 25 in the online early edition of ...
... HOUSTON, Oct. 25, 2010 Some unexpected effects ... and reverse blindness have been uncovered by a University ... Donald A. Fox, a professor of vision sciences ... findings in a paper titled "Low-Level Gestational Lead Exposure ...
Cached Biology News:UF research gives clues about carbon dioxide patterns at end of Ice Age 2UF research gives clues about carbon dioxide patterns at end of Ice Age 3Unexpected findings of lead exposure may lead to treating blindness 2Unexpected findings of lead exposure may lead to treating blindness 3
... paraffin tissue array is designed for ... interest in extensive panels of different ... heart, kidney, liver, lung, muscle, spleen ... positively charged glass slide. Each ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
in vitro Translation, Accessory Products...
Biology Products: